Compare NTB & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NTB | PAHC |
|---|---|---|
| Founded | 1858 | 1946 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2016 | 2014 |
| Metric | NTB | PAHC |
|---|---|---|
| Price | $51.96 | $40.96 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 3 | 4 |
| Target Price | ★ $50.67 | $31.25 |
| AVG Volume (30 Days) | 159.4K | ★ 273.3K |
| Earning Date | 10-28-2025 | 02-04-2026 |
| Dividend Yield | ★ 3.89% | 1.18% |
| EPS Growth | 17.07 | ★ 288.74 |
| EPS | ★ 5.27 | 1.67 |
| Revenue | $599,452,000.00 | ★ $1,399,676,000.00 |
| Revenue This Year | $4.46 | $15.34 |
| Revenue Next Year | N/A | $3.28 |
| P/E Ratio | ★ $9.75 | $24.30 |
| Revenue Growth | 4.60 | ★ 33.72 |
| 52 Week Low | $34.77 | $16.16 |
| 52 Week High | $51.83 | $46.42 |
| Indicator | NTB | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 82.82 | 48.75 |
| Support Level | $50.80 | $39.39 |
| Resistance Level | $51.83 | $41.62 |
| Average True Range (ATR) | 0.91 | 1.66 |
| MACD | 0.22 | -0.02 |
| Stochastic Oscillator | 95.06 | 63.50 |
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.